CroíValve

Description

CroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in patients; device is under clinical investigation for healthcare providers.

CroíValve is located in the Dublin ecosystem.

Related

• Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
• NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
• Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
• SympheraSymphera develops an integrated surgical system that combines multiple instruments into one device, enabling intra-body tool switching to…
• UroMemsUroMems develops smart active implantable medical devices for treating stress urinary incontinence, including the UroActive system for…
• Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
• CorWaveCorWave develops an implantable left ventricular assist pump that uses a wave membrane to produce truly pulsatile blood flow for treating…
• BOYDSenseBOYDSense develops non-invasive, pain-free health monitoring technology and devices for multi-condition detection and monitoring, with an…
• FIRE1FIRE1 develops NORM, an investigational heart failure management system that combines an implanted sensor in the inferior vena cava with a…